HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels - Trial NCT04610762
Access comprehensive clinical trial information for NCT04610762 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Universitaire Saint Pierre and is currently Not yet recruiting. The study focuses on Hepatitis C, Chronic. Target enrollment is 300 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Centre Hospitalier Universitaire Saint Pierre
Timeline & Enrollment
N/A
Nov 17, 2020
Dec 01, 2022
Primary Outcome
Evaluation of interest and impact of this new method by the number of participants tested in outreach approaches
Summary
The main objective of this study is to assess the interest (linkage to care) of the Cepheid
 GeneXpert HCV VL Fingerstick test in Brussels among drug users or former users in contact
 with the Réseau Hépatite C Bruxelles organization through different partners of this network.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04610762
Non-Device Trial